TableĀ 1

Demographic and clinical data of subjects bearing the [p.Arg74Trp;p.Val201Met;p.Asp1270Asn] or the [p.Arg74Trp;p.Asp1270Asn] complex alleles or the p.Asp1270Asn mutation

GenderCurrent age (years)DiagnosisAge at diagnosis/enrolment (years)Cause of diagnosis/enrolmentAllele 1Allele 2SCL* (mmol/L)Current FEV1 (%)Pancreatic statusCFTR gating (%)Other
M36CF19Hypochloremic alkalosisp.[Arg74Trp;Val201Met;Asp1270Asn]p.Phe508del89104PSn.a.CBAVD
F58CF53Familiarityp.[Arg74Trp;Val201Met;Asp1270Asn]p.Phe508del62105PS12.0
F21CF9Familiarityp.[Arg74Trp;Val201Met;Asp1270Asn]p.Asn1303Lys109119PS9.8IGT
F23CF10Respiratoryp.[Arg74Trp;Val201Met;Asp1270Asn]p.Asn1303Lys6595PS11.8IGT; bronchiectasis
M12CFTR-RD6Respiratoryp.[Arg74Trp;Val201Met;Asp1270Asn]p.Phe508del3787PS15.0
M13CFTR-RD1Hypochloremic alkalosisp.[Arg74Trp;Val201Met;Asp1270Asn]p.Ser1206*4691PSn.a.
M37CFTR-RD32CBAVDp.[Arg74Trp;Val201Met;Asp1270Asn]p.Asp579Gly11899PS19.1
M48CFTR-RD42CBAVDp.[Arg74Trp;Val201Met;Asp1270Asn]p.Asp1152His31n.a.PS18.5
M40CFTR-RD34CBAVDp.[Arg74Trp;Asp1270Asn]c.[1210-34TG[12];1210-12T[5]]32n.a.PS18.9
F5Healthy1NBSp.[Arg74Trp;Asp1270Asn]p.Phe508del11n.a.PSn.a.
M40Healthy35Familiarityp.Asp1270Asnp.Asn1303Lys9n.a.PSn.a.
M40Healthy35Familiarityp.Asp1270Asnp.Phe508del12n.a.PS44.0
M50Healthy40Familiarityp.[Arg74Trp;Asp1270Asn]Nn.a.n.a.n.a.92.6
F47Healthy47Familiarityp.[Arg74Trp;Asp1270Asn]Nn.a.n.a.n.a.94.0
  • *For patients with CF, we reported SCL at diagnosis while for CFTR-RD and for healthy subjects we reported current SCL; values in italics represent SCL discordant with diagnosis.

  • CBAVD, congenital bilateral absence of vas deferens; CF, cystic fibrosis; CFTR-RD, cystic fibrosis transmembrane conductance regulator -related disorders; FEV1, forced expiratory volume in 1 second; IGT, impaired glucose tolerance; n.a., not assessed; N, wild-type allele; NBS, newborn screening; PS, pancreatic sufficiency; SCL, sweat chloride level.